Germany advised to combine AstraZeneca and mRNA vaccines to brake Delta variant

AstraZeneca

10,292.00p

16:49 14/11/24

1.46%

148.00p

Germany's government committee on vaccinations believes combining the Covid-19 vaccine made by AstraZeneca and mRNA ones such as Pfizer's is the best way to combat the so-called Delta variant.

FTSE 100

8,071.19

16:49 14/11/24

n/a

FTSE 350

4,459.02

16:38 14/11/24

n/a

FTSE All-Share

4,417.25

16:54 14/11/24

n/a

MODERNA

$39.77

13:09 14/11/24

-5.62%

-$2.37

Pfizer Inc.

$26.02

11:10 14/11/24

-2.62%

-$0.70

Pharmaceuticals & Biotechnology

19,794.96

16:38 14/11/24

0.96%

187.95

According to the committee (Stiko), the immune response generated from a combination of one shot of each is "clearly superior to that from two doses of AstraZeneca alone".

Its recommendation was for the second jab to be given four week after a first shot with AstraZeneca's vaccine.

At last count, roughly 55% of the total German population had received at least one dose and a further 37.3% the complete vaccine course.

However, according to German health minister, Jens Spahn, starting from June the proportion of infections in Germany from the Delta variant was set to reach 70-80% of the total.